Related Experiment Video
Updated: Jun 14, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure
Blake Gregory1, Anne M Larson, Joan Reisch
1University of Texas Southwestern Medical Center at Dallas, TX, USA. beg81@mac.com <beg81@mac.com>
Summary
Acetaminophen overdose can cause acute liver failure (ALF). Study found acetaminophen dose did not predict ALF prognosis; coma grade was more significant.
Area of Science:
- Hepatology
- Toxicology
- Clinical Medicine
Background:
- Acetaminophen is a common cause of drug-induced liver injury.
- Dose ingested is often considered a key factor in acetaminophen toxicity outcomes.
- Acute liver failure (ALF) from acetaminophen overdose presents a significant clinical challenge.
Purpose of the Study:
- To evaluate the prognostic value of acetaminophen dose in patients with ALF.
- To determine if acetaminophen dose correlates with clinical outcomes and survival.
- To assess the utility of dosing information in managing acetaminophen-induced ALF.
Main Methods:
- Prospective analysis of 113 patients with ALF due to acetaminophen.
- Statistical methods included multivariate and chi-square tests.
- Mann-Whitney U test compared prognosis and survival based on dose.
Main Results:
- No significant relationship was found between acetaminophen dose and spontaneous survival.
- Acetaminophen dose did not correlate with clinical prognostic indicators.
- Statistical analyses failed to establish dose as a predictor of outcome.
Conclusions:
- Acetaminophen dose is not a reliable prognostic indicator in ALF.
- Coma grade on admission is a more significant predictor of prognosis.
- Encephalopathy severity offers a more reliable assessment of patient outcomes than dose information.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...